MEDIPOST Co., Ltd. (KOSDAQ:078160)

South Korea flag South Korea · Delayed Price · Currency is KRW
19,110
-890 (-4.45%)
At close: Dec 5, 2025
79.61%
Market Cap 746.93B
Revenue (ttm) 73.59B
Net Income (ttm) -97.90B
Shares Out 39.09M
EPS (ttm) -2,925.61
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 109,614
Average Volume 108,571
Open 20,150
Previous Close 20,000
Day's Range 19,020 - 20,150
52-Week Range 7,490 - 20,500
Beta 0.71
RSI 62.73
Earnings Date Nov 13, 2025

About MEDIPOST

MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally. The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food. It operates cord blood bank under the CELLTREE name. The company also offers CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis. In addition, it is developing stem cell products, such as PNEUMOSTEM for the preventative treatment of bronchopulmonary dysplasia. Further, the co... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 322
Stock Exchange KOSDAQ
Ticker Symbol 078160
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.